IMMP

1.70

3.03% 0.05

Handel nachbörslich: 1.73 0.03 +1.76%

Immutep Limited Adr (IMMP)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.65

Offen:

$1.6301

24-Stunden-Volumen:

62,557

Relative Volume:

0.23

Marktkapitalisierung:

$270.74M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

-7.5656

EPS:

-0.2247

Netto-Cashflow:

1W Leistung:

+8.28%

1M Leistung:

-8.60%

6M Leistung:

-23.08%

1J Leistung:

-9.57%

1-Tages-Spanne:

$1.63

$1.70

1-Wochen-Bereich:

$1.5597

$1.71

52-Wochen-Spanne:

$1.32

$2.72

Immutep Limited Adr Stock (IMMP) Company Profile

Firmenname

Immutep Limited Adr

Sektor

Healthcare (1166)

Branche

Biotechnology (655)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-02-24

Neueste SEC-Einreichungen

IMMP's Discussions on Twitter

Vergleichen Sie IMMP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IMMP Immutep Limited Adr	1.70	270.74M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	457.03	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	547.74	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	329.77	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	545.11	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	244.32	28.51B	3.81B	-644.79M	-669.77M	-6.24

Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-05-17	Eingeleitet	CapitalOne	Overweight
2023-08-03	Eingeleitet	Robert W. Baird	Outperform
2021-08-03	Eingeleitet	Ladenburg Thalmann	Buy
2021-07-16	Fortgesetzt	Maxim Group	Buy
2018-09-28	Eingeleitet	B. Riley FBR	Buy
2018-02-15	Bestätigt	Maxim Group	Buy

Alle ansehen

Immutep Limited Adr Aktie (IMMP) Neueste Nachrichten

Jun 15, 2025

Millennium Management LLC Sells 19,242 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 15, 2025

Jun 08, 2025

Jane Street Group LLC Has $98,000 Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 08, 2025

Jun 01, 2025

Immutep Ltd Highlights Immune System Innovations at Healthcare Conference - TipRanks

Jun 01, 2025

May 08, 2025

Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX

May 08, 2025

May 06, 2025

Immutep stock soars on promising trial results - Investing.com Australia

May 06, 2025

May 05, 2025

Immutep stock soars on promising trial results By Investing.com - Investing.com Nigeria

May 05, 2025

Apr 29, 2025

Immutep Quarterly Activities Report Q3 FY25 - The Manila Times

Apr 29, 2025

Apr 02, 2025

Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Apr 02, 2025

Mar 24, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025

Feb 11, 2025

Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest

Feb 11, 2025

Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025

Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024

Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewswire

Dec 17, 2024

Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024

Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - Yahoo Finance

Oct 17, 2024

Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024

Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024

Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024

Nov 27, 2023